Global Mepolizumab Market Growth 2026-2032
The global Mepolizumab market size is predicted to grow from US$ 2597 million in 2025 to US$ 7271 million in 2032; it is expected to grow at a CAGR of 17.3% from 2026 to 2032.
Mepolizumab is a humanized anti?interleukin?5 (IL?5) monoclonal antibody drug. It specifically targets and binds to the IL?5 cytokine, blocks its combination with receptors on the surface of eosinophils, and inhibits the activation, proliferation and survival of eosinophils, thereby reducing eosinophilic inflammatory responses in the respiratory tract and the whole body. It is mainly applied in the treatment of inflammatory diseases such as eosinophilic asthma and chronic rhinosinusitis with nasal polyps. With stable clinical efficacy and favorable safety, it can effectively reduce the risk of severe exacerbations and provide a long?acting targeted treatment option for eosinophil?related respiratory diseases.In 2025, global Mepolizumab (Nucala) production reached approximately 1.71 million vials.
Mepolizumab, the world?s first approved anti?IL?5 monoclonal antibody, targets eosinophil?related diseases mediated by interleukin?5. It has built a diversified product portfolio centered on severe asthma, with gradually expanded indications including chronic rhinosinusitis with nasal polyps and eosinophilic granulomatosis with polyangiitis. Its market development is driven by the popularization of precision diagnosis and treatment as well as the general shift toward biological agents. Global regulatory authorities continue to expand its applicable populations and age ranges, meanwhile promoting its penetration from hospital settings to outpatient and home care scenarios. In terms of competition, GSK occupies a leading position, continuously optimizing its indication spectrum through clinical research and developing next?generation long?acting formulations to improve patient compliance and market competitiveness. Regional market growth benefits from improved medical infrastructure and rising awareness of rare and refractory inflammatory diseases, with emerging markets such as the Asia?Pacific region showing great growth potential. Overall, key market drivers include improved diagnostic capabilities, greater accessibility of biological drugs, and optimized long?term treatment costs. Major challenges involve difficulties in target patient screening, inconsistent reimbursement policies, and competition from similar therapeutic drugs. The overall industry development is characterized by indication expansion, regional market penetration and continuous product iteration.
LP Information, Inc. (LPI) ' newest research report, the ?Mepolizumab Industry Forecast? looks at past sales and reviews total world Mepolizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Mepolizumab sales for 2026 through 2032. With Mepolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mepolizumab industry.
This Insight Report provides a comprehensive analysis of the global Mepolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mepolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mepolizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mepolizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mepolizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Mepolizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mepolizumab market?
What factors are driving Mepolizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mepolizumab market opportunities vary by end market size?
How does Mepolizumab break out by Type, by Application?
Mepolizumab is a humanized anti?interleukin?5 (IL?5) monoclonal antibody drug. It specifically targets and binds to the IL?5 cytokine, blocks its combination with receptors on the surface of eosinophils, and inhibits the activation, proliferation and survival of eosinophils, thereby reducing eosinophilic inflammatory responses in the respiratory tract and the whole body. It is mainly applied in the treatment of inflammatory diseases such as eosinophilic asthma and chronic rhinosinusitis with nasal polyps. With stable clinical efficacy and favorable safety, it can effectively reduce the risk of severe exacerbations and provide a long?acting targeted treatment option for eosinophil?related respiratory diseases.In 2025, global Mepolizumab (Nucala) production reached approximately 1.71 million vials.
Mepolizumab, the world?s first approved anti?IL?5 monoclonal antibody, targets eosinophil?related diseases mediated by interleukin?5. It has built a diversified product portfolio centered on severe asthma, with gradually expanded indications including chronic rhinosinusitis with nasal polyps and eosinophilic granulomatosis with polyangiitis. Its market development is driven by the popularization of precision diagnosis and treatment as well as the general shift toward biological agents. Global regulatory authorities continue to expand its applicable populations and age ranges, meanwhile promoting its penetration from hospital settings to outpatient and home care scenarios. In terms of competition, GSK occupies a leading position, continuously optimizing its indication spectrum through clinical research and developing next?generation long?acting formulations to improve patient compliance and market competitiveness. Regional market growth benefits from improved medical infrastructure and rising awareness of rare and refractory inflammatory diseases, with emerging markets such as the Asia?Pacific region showing great growth potential. Overall, key market drivers include improved diagnostic capabilities, greater accessibility of biological drugs, and optimized long?term treatment costs. Major challenges involve difficulties in target patient screening, inconsistent reimbursement policies, and competition from similar therapeutic drugs. The overall industry development is characterized by indication expansion, regional market penetration and continuous product iteration.
LP Information, Inc. (LPI) ' newest research report, the ?Mepolizumab Industry Forecast? looks at past sales and reviews total world Mepolizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Mepolizumab sales for 2026 through 2032. With Mepolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mepolizumab industry.
This Insight Report provides a comprehensive analysis of the global Mepolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mepolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mepolizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mepolizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mepolizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Mepolizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100mg Pre?filled Syringe
- 100mg Lyophilized Powder for Injection
- Combination of Mepolizumab and Inhaled Corticosteroids
- Combination of Mepolizumab and LABA
- Subcutaneous Injection
- Subcutaneous Infusion
- Hospital
- Retail
- Online
- Severe Eosinophilic Asthma
- Chronic Rhinosinusitis With Nasal Polyps
- Eosinophilic Granulomatosis With Polyangiitis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK, GlaxoSmithKline
What is the 10-year outlook for the global Mepolizumab market?
What factors are driving Mepolizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mepolizumab market opportunities vary by end market size?
How does Mepolizumab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mepolizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mepolizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mepolizumab by Country/Region, 2021, 2025 & 2032
2.2 Mepolizumab Segment by Type
2.2.1 100mg Pre?filled Syringe
2.2.2 100mg Lyophilized Powder for Injection
2.2.3 Mepolizumab Sales by Type
2.2.3.1 Global Mepolizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mepolizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mepolizumab Sale Price by Type (2021-2026)
2.3 Mepolizumab Segment by Combination Therapy
2.3.1 Combination of Mepolizumab and Inhaled Corticosteroids
2.3.2 Combination of Mepolizumab and LABA
2.3.3 Mepolizumab Sales by Combination Therapy
2.3.3.1 Global Mepolizumab Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Mepolizumab Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Mepolizumab Sale Price by Combination Therapy (2021-2026)
2.4 Mepolizumab Segment by Route of Administratio
2.4.1 Subcutaneous Injection
2.4.2 Subcutaneous Infusion
2.4.3 Mepolizumab Sales by Route of Administratio
2.4.3.1 Global Mepolizumab Sales Market Share by Route of Administratio (2021-2026)
2.4.3.2 Global Mepolizumab Revenue and Market Share by Route of Administratio (2021-2026)
2.4.3.3 Global Mepolizumab Sale Price by Route of Administratio (2021-2026)
2.5 Mepolizumab Segment by Sales Channel
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Mepolizumab Sales by Sales Channel
2.5.4.1 Global Mepolizumab Sales Market Share by Sales Channel (2021-2026)
2.5.4.2 Global Mepolizumab Revenue and Market Share by Sales Channel (2021-2026)
2.5.4.3 Global Mepolizumab Sale Price by Sales Channel (2021-2026)
2.6 Mepolizumab Segment by Application
2.6.1 Severe Eosinophilic Asthma
2.6.2 Chronic Rhinosinusitis With Nasal Polyps
2.6.3 Eosinophilic Granulomatosis With Polyangiitis
2.6.4 Others
2.6.5 Mepolizumab Sales by Application
2.6.5.1 Global Mepolizumab Sale Market Share by Application (2021-2026)
2.6.5.2 Global Mepolizumab Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Mepolizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mepolizumab Breakdown Data by Company
3.1.1 Global Mepolizumab Annual Sales by Company (2021-2026)
3.1.2 Global Mepolizumab Sales Market Share by Company (2021-2026)
3.2 Global Mepolizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Mepolizumab Revenue by Company (2021-2026)
3.2.2 Global Mepolizumab Revenue Market Share by Company (2021-2026)
3.3 Global Mepolizumab Sale Price by Company
3.4 Key Manufacturers Mepolizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mepolizumab Product Location Distribution
3.4.2 Players Mepolizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEPOLIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Mepolizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Mepolizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mepolizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mepolizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Mepolizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mepolizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mepolizumab Sales Growth
4.4 APAC Mepolizumab Sales Growth
4.5 Europe Mepolizumab Sales Growth
4.6 Middle East & Africa Mepolizumab Sales Growth
5 AMERICAS
5.1 Americas Mepolizumab Sales by Country
5.1.1 Americas Mepolizumab Sales by Country (2021-2026)
5.1.2 Americas Mepolizumab Revenue by Country (2021-2026)
5.2 Americas Mepolizumab Sales by Type (2021-2026)
5.3 Americas Mepolizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mepolizumab Sales by Region
6.1.1 APAC Mepolizumab Sales by Region (2021-2026)
6.1.2 APAC Mepolizumab Revenue by Region (2021-2026)
6.2 APAC Mepolizumab Sales by Type (2021-2026)
6.3 APAC Mepolizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mepolizumab by Country
7.1.1 Europe Mepolizumab Sales by Country (2021-2026)
7.1.2 Europe Mepolizumab Revenue by Country (2021-2026)
7.2 Europe Mepolizumab Sales by Type (2021-2026)
7.3 Europe Mepolizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mepolizumab by Country
8.1.1 Middle East & Africa Mepolizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mepolizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Mepolizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Mepolizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mepolizumab
10.3 Manufacturing Process Analysis of Mepolizumab
10.4 Industry Chain Structure of Mepolizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mepolizumab Distributors
11.3 Mepolizumab Customer
12 WORLD FORECAST REVIEW FOR MEPOLIZUMAB BY GEOGRAPHIC REGION
12.1 Global Mepolizumab Market Size Forecast by Region
12.1.1 Global Mepolizumab Forecast by Region (2027-2032)
12.1.2 Global Mepolizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mepolizumab Forecast by Type (2027-2032)
12.7 Global Mepolizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK, GlaxoSmithKline
13.1.1 GSK, GlaxoSmithKline Company Information
13.1.2 GSK, GlaxoSmithKline Mepolizumab Product Portfolios and Specifications
13.1.3 GSK, GlaxoSmithKline Mepolizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK, GlaxoSmithKline Main Business Overview
13.1.5 GSK, GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mepolizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mepolizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mepolizumab by Country/Region, 2021, 2025 & 2032
2.2 Mepolizumab Segment by Type
2.2.1 100mg Pre?filled Syringe
2.2.2 100mg Lyophilized Powder for Injection
2.2.3 Mepolizumab Sales by Type
2.2.3.1 Global Mepolizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mepolizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mepolizumab Sale Price by Type (2021-2026)
2.3 Mepolizumab Segment by Combination Therapy
2.3.1 Combination of Mepolizumab and Inhaled Corticosteroids
2.3.2 Combination of Mepolizumab and LABA
2.3.3 Mepolizumab Sales by Combination Therapy
2.3.3.1 Global Mepolizumab Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Mepolizumab Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Mepolizumab Sale Price by Combination Therapy (2021-2026)
2.4 Mepolizumab Segment by Route of Administratio
2.4.1 Subcutaneous Injection
2.4.2 Subcutaneous Infusion
2.4.3 Mepolizumab Sales by Route of Administratio
2.4.3.1 Global Mepolizumab Sales Market Share by Route of Administratio (2021-2026)
2.4.3.2 Global Mepolizumab Revenue and Market Share by Route of Administratio (2021-2026)
2.4.3.3 Global Mepolizumab Sale Price by Route of Administratio (2021-2026)
2.5 Mepolizumab Segment by Sales Channel
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 Mepolizumab Sales by Sales Channel
2.5.4.1 Global Mepolizumab Sales Market Share by Sales Channel (2021-2026)
2.5.4.2 Global Mepolizumab Revenue and Market Share by Sales Channel (2021-2026)
2.5.4.3 Global Mepolizumab Sale Price by Sales Channel (2021-2026)
2.6 Mepolizumab Segment by Application
2.6.1 Severe Eosinophilic Asthma
2.6.2 Chronic Rhinosinusitis With Nasal Polyps
2.6.3 Eosinophilic Granulomatosis With Polyangiitis
2.6.4 Others
2.6.5 Mepolizumab Sales by Application
2.6.5.1 Global Mepolizumab Sale Market Share by Application (2021-2026)
2.6.5.2 Global Mepolizumab Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Mepolizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mepolizumab Breakdown Data by Company
3.1.1 Global Mepolizumab Annual Sales by Company (2021-2026)
3.1.2 Global Mepolizumab Sales Market Share by Company (2021-2026)
3.2 Global Mepolizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Mepolizumab Revenue by Company (2021-2026)
3.2.2 Global Mepolizumab Revenue Market Share by Company (2021-2026)
3.3 Global Mepolizumab Sale Price by Company
3.4 Key Manufacturers Mepolizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mepolizumab Product Location Distribution
3.4.2 Players Mepolizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEPOLIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Mepolizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Mepolizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mepolizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mepolizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Mepolizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mepolizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mepolizumab Sales Growth
4.4 APAC Mepolizumab Sales Growth
4.5 Europe Mepolizumab Sales Growth
4.6 Middle East & Africa Mepolizumab Sales Growth
5 AMERICAS
5.1 Americas Mepolizumab Sales by Country
5.1.1 Americas Mepolizumab Sales by Country (2021-2026)
5.1.2 Americas Mepolizumab Revenue by Country (2021-2026)
5.2 Americas Mepolizumab Sales by Type (2021-2026)
5.3 Americas Mepolizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mepolizumab Sales by Region
6.1.1 APAC Mepolizumab Sales by Region (2021-2026)
6.1.2 APAC Mepolizumab Revenue by Region (2021-2026)
6.2 APAC Mepolizumab Sales by Type (2021-2026)
6.3 APAC Mepolizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mepolizumab by Country
7.1.1 Europe Mepolizumab Sales by Country (2021-2026)
7.1.2 Europe Mepolizumab Revenue by Country (2021-2026)
7.2 Europe Mepolizumab Sales by Type (2021-2026)
7.3 Europe Mepolizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mepolizumab by Country
8.1.1 Middle East & Africa Mepolizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mepolizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Mepolizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Mepolizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mepolizumab
10.3 Manufacturing Process Analysis of Mepolizumab
10.4 Industry Chain Structure of Mepolizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mepolizumab Distributors
11.3 Mepolizumab Customer
12 WORLD FORECAST REVIEW FOR MEPOLIZUMAB BY GEOGRAPHIC REGION
12.1 Global Mepolizumab Market Size Forecast by Region
12.1.1 Global Mepolizumab Forecast by Region (2027-2032)
12.1.2 Global Mepolizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mepolizumab Forecast by Type (2027-2032)
12.7 Global Mepolizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK, GlaxoSmithKline
13.1.1 GSK, GlaxoSmithKline Company Information
13.1.2 GSK, GlaxoSmithKline Mepolizumab Product Portfolios and Specifications
13.1.3 GSK, GlaxoSmithKline Mepolizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK, GlaxoSmithKline Main Business Overview
13.1.5 GSK, GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mepolizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mepolizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg Pre?filled Syringe
Table 4. Major Players of 100mg Lyophilized Powder for Injection
Table 5. Global Mepolizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Mepolizumab Sales Market Share by Type (2021-2026)
Table 7. Global Mepolizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mepolizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Mepolizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Combination of Mepolizumab and Inhaled Corticosteroids
Table 11. Major Players of Combination of Mepolizumab and LABA
Table 12. Global Mepolizumab Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Mepolizumab Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Mepolizumab Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Mepolizumab Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Mepolizumab Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Subcutaneous Injection
Table 18. Major Players of Subcutaneous Infusion
Table 19. Global Mepolizumab Sales by Route of Administratio (2021-2026) & (Units)
Table 20. Global Mepolizumab Sales Market Share by Route of Administratio (2021-2026)
Table 21. Global Mepolizumab Revenue by Route of Administratio (2021-2026) & ($ million)
Table 22. Global Mepolizumab Revenue Market Share by Route of Administratio (2021-2026)
Table 23. Global Mepolizumab Sale Price by Route of Administratio (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Mepolizumab Sales by Sales Channel (2021-2026) & (Units)
Table 28. Global Mepolizumab Sales Market Share by Sales Channel (2021-2026)
Table 29. Global Mepolizumab Revenue by Sales Channel (2021-2026) & ($ million)
Table 30. Global Mepolizumab Revenue Market Share by Sales Channel (2021-2026)
Table 31. Global Mepolizumab Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 32. Global Mepolizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Mepolizumab Sale Market Share by Application (2021-2026)
Table 34. Global Mepolizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Mepolizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Mepolizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Mepolizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Mepolizumab Sales Market Share by Company (2021-2026)
Table 39. Global Mepolizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Mepolizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Mepolizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Mepolizumab Producing Area Distribution and Sales Area
Table 43. Players Mepolizumab Products Offered
Table 44. Mepolizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Mepolizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Mepolizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Mepolizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Mepolizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Mepolizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Mepolizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Mepolizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Mepolizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Mepolizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Mepolizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Mepolizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Mepolizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Mepolizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Mepolizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Mepolizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Mepolizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Mepolizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Mepolizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Mepolizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Mepolizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Mepolizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Mepolizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Mepolizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Mepolizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Mepolizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Mepolizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Mepolizumab
Table 74. Key Market Challenges & Risks of Mepolizumab
Table 75. Key Industry Trends of Mepolizumab
Table 76. Mepolizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Mepolizumab Distributors List
Table 79. Mepolizumab Customer List
Table 80. Global Mepolizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Mepolizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Mepolizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Mepolizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Mepolizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Mepolizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Mepolizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Mepolizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Mepolizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Mepolizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Mepolizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. GSK, GlaxoSmithKline Basic Information, Mepolizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. GSK, GlaxoSmithKline Mepolizumab Product Portfolios and Specifications
Table 96. GSK, GlaxoSmithKline Mepolizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GSK, GlaxoSmithKline Main Business
Table 98. GSK, GlaxoSmithKline Latest Developments
Table 1. Mepolizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mepolizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg Pre?filled Syringe
Table 4. Major Players of 100mg Lyophilized Powder for Injection
Table 5. Global Mepolizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Mepolizumab Sales Market Share by Type (2021-2026)
Table 7. Global Mepolizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mepolizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Mepolizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Combination of Mepolizumab and Inhaled Corticosteroids
Table 11. Major Players of Combination of Mepolizumab and LABA
Table 12. Global Mepolizumab Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Mepolizumab Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Mepolizumab Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Mepolizumab Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Mepolizumab Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Subcutaneous Injection
Table 18. Major Players of Subcutaneous Infusion
Table 19. Global Mepolizumab Sales by Route of Administratio (2021-2026) & (Units)
Table 20. Global Mepolizumab Sales Market Share by Route of Administratio (2021-2026)
Table 21. Global Mepolizumab Revenue by Route of Administratio (2021-2026) & ($ million)
Table 22. Global Mepolizumab Revenue Market Share by Route of Administratio (2021-2026)
Table 23. Global Mepolizumab Sale Price by Route of Administratio (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global Mepolizumab Sales by Sales Channel (2021-2026) & (Units)
Table 28. Global Mepolizumab Sales Market Share by Sales Channel (2021-2026)
Table 29. Global Mepolizumab Revenue by Sales Channel (2021-2026) & ($ million)
Table 30. Global Mepolizumab Revenue Market Share by Sales Channel (2021-2026)
Table 31. Global Mepolizumab Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 32. Global Mepolizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Mepolizumab Sale Market Share by Application (2021-2026)
Table 34. Global Mepolizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Mepolizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Mepolizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Mepolizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Mepolizumab Sales Market Share by Company (2021-2026)
Table 39. Global Mepolizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Mepolizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Mepolizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Mepolizumab Producing Area Distribution and Sales Area
Table 43. Players Mepolizumab Products Offered
Table 44. Mepolizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Mepolizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Mepolizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Mepolizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Mepolizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Mepolizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Mepolizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Mepolizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Mepolizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Mepolizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Mepolizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Mepolizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Mepolizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Mepolizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Mepolizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Mepolizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Mepolizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Mepolizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Mepolizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Mepolizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Mepolizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Mepolizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Mepolizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Mepolizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Mepolizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Mepolizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Mepolizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Mepolizumab
Table 74. Key Market Challenges & Risks of Mepolizumab
Table 75. Key Industry Trends of Mepolizumab
Table 76. Mepolizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Mepolizumab Distributors List
Table 79. Mepolizumab Customer List
Table 80. Global Mepolizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Mepolizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Mepolizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Mepolizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Mepolizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Mepolizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Mepolizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Mepolizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Mepolizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Mepolizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Mepolizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Mepolizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. GSK, GlaxoSmithKline Basic Information, Mepolizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. GSK, GlaxoSmithKline Mepolizumab Product Portfolios and Specifications
Table 96. GSK, GlaxoSmithKline Mepolizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GSK, GlaxoSmithKline Main Business
Table 98. GSK, GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mepolizumab
Figure 2. Mepolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mepolizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mepolizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mepolizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mepolizumab Sales Market Share by Country/Region (2025)
Figure 10. Mepolizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg Pre?filled Syringe
Figure 12. Product Picture of 100mg Lyophilized Powder for Injection
Figure 13. Global Mepolizumab Sales Market Share by Type in 2026
Figure 14. Global Mepolizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Combination of Mepolizumab and Inhaled Corticosteroids
Figure 16. Product Picture of Combination of Mepolizumab and LABA
Figure 17. Global Mepolizumab Sales Market Share by Combination Therapy in 2026
Figure 18. Global Mepolizumab Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Subcutaneous Injection
Figure 20. Product Picture of Subcutaneous Infusion
Figure 21. Global Mepolizumab Sales Market Share by Route of Administratio in 2026
Figure 22. Global Mepolizumab Revenue Market Share by Route of Administratio (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Mepolizumab Sales Market Share by Sales Channel in 2026
Figure 27. Global Mepolizumab Revenue Market Share by Sales Channel (2021-2026)
Figure 28. Mepolizumab Consumed in Severe Eosinophilic Asthma
Figure 29. Global Mepolizumab Market: Severe Eosinophilic Asthma (2021-2026) & (Units)
Figure 30. Mepolizumab Consumed in Chronic Rhinosinusitis With Nasal Polyps
Figure 31. Global Mepolizumab Market: Chronic Rhinosinusitis With Nasal Polyps (2021-2026) & (Units)
Figure 32. Mepolizumab Consumed in Eosinophilic Granulomatosis With Polyangiitis
Figure 33. Global Mepolizumab Market: Eosinophilic Granulomatosis With Polyangiitis (2021-2026) & (Units)
Figure 34. Mepolizumab Consumed in Others
Figure 35. Global Mepolizumab Market: Others (2021-2026) & (Units)
Figure 36. Global Mepolizumab Sale Market Share by Application (2025)
Figure 37. Global Mepolizumab Revenue Market Share by Application in 2025
Figure 38. Mepolizumab Sales by Company in 2025 (Units)
Figure 39. Global Mepolizumab Sales Market Share by Company in 2025
Figure 40. Mepolizumab Revenue by Company in 2025 ($ millions)
Figure 41. Global Mepolizumab Revenue Market Share by Company in 2025
Figure 42. Global Mepolizumab Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Mepolizumab Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Mepolizumab Sales 2021-2026 (Units)
Figure 45. Americas Mepolizumab Revenue 2021-2026 ($ millions)
Figure 46. APAC Mepolizumab Sales 2021-2026 (Units)
Figure 47. APAC Mepolizumab Revenue 2021-2026 ($ millions)
Figure 48. Europe Mepolizumab Sales 2021-2026 (Units)
Figure 49. Europe Mepolizumab Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Mepolizumab Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Mepolizumab Revenue 2021-2026 ($ millions)
Figure 52. Americas Mepolizumab Sales Market Share by Country in 2025
Figure 53. Americas Mepolizumab Revenue Market Share by Country (2021-2026)
Figure 54. Americas Mepolizumab Sales Market Share by Type (2021-2026)
Figure 55. Americas Mepolizumab Sales Market Share by Application (2021-2026)
Figure 56. United States Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Mepolizumab Sales Market Share by Region in 2025
Figure 61. APAC Mepolizumab Revenue Market Share by Region (2021-2026)
Figure 62. APAC Mepolizumab Sales Market Share by Type (2021-2026)
Figure 63. APAC Mepolizumab Sales Market Share by Application (2021-2026)
Figure 64. China Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. India Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Mepolizumab Sales Market Share by Country in 2025
Figure 72. Europe Mepolizumab Revenue Market Share by Country (2021-2026)
Figure 73. Europe Mepolizumab Sales Market Share by Type (2021-2026)
Figure 74. Europe Mepolizumab Sales Market Share by Application (2021-2026)
Figure 75. Germany Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. France Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Mepolizumab Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Mepolizumab Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Mepolizumab Sales Market Share by Application (2021-2026)
Figure 83. Egypt Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Mepolizumab in 2026
Figure 89. Manufacturing Process Analysis of Mepolizumab
Figure 90. Industry Chain Structure of Mepolizumab
Figure 91. Channels of Distribution
Figure 92. Global Mepolizumab Sales Market Forecast by Region (2027-2032)
Figure 93. Global Mepolizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Mepolizumab Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Mepolizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Mepolizumab Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Mepolizumab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Mepolizumab
Figure 2. Mepolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mepolizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mepolizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mepolizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mepolizumab Sales Market Share by Country/Region (2025)
Figure 10. Mepolizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg Pre?filled Syringe
Figure 12. Product Picture of 100mg Lyophilized Powder for Injection
Figure 13. Global Mepolizumab Sales Market Share by Type in 2026
Figure 14. Global Mepolizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Combination of Mepolizumab and Inhaled Corticosteroids
Figure 16. Product Picture of Combination of Mepolizumab and LABA
Figure 17. Global Mepolizumab Sales Market Share by Combination Therapy in 2026
Figure 18. Global Mepolizumab Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Subcutaneous Injection
Figure 20. Product Picture of Subcutaneous Infusion
Figure 21. Global Mepolizumab Sales Market Share by Route of Administratio in 2026
Figure 22. Global Mepolizumab Revenue Market Share by Route of Administratio (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global Mepolizumab Sales Market Share by Sales Channel in 2026
Figure 27. Global Mepolizumab Revenue Market Share by Sales Channel (2021-2026)
Figure 28. Mepolizumab Consumed in Severe Eosinophilic Asthma
Figure 29. Global Mepolizumab Market: Severe Eosinophilic Asthma (2021-2026) & (Units)
Figure 30. Mepolizumab Consumed in Chronic Rhinosinusitis With Nasal Polyps
Figure 31. Global Mepolizumab Market: Chronic Rhinosinusitis With Nasal Polyps (2021-2026) & (Units)
Figure 32. Mepolizumab Consumed in Eosinophilic Granulomatosis With Polyangiitis
Figure 33. Global Mepolizumab Market: Eosinophilic Granulomatosis With Polyangiitis (2021-2026) & (Units)
Figure 34. Mepolizumab Consumed in Others
Figure 35. Global Mepolizumab Market: Others (2021-2026) & (Units)
Figure 36. Global Mepolizumab Sale Market Share by Application (2025)
Figure 37. Global Mepolizumab Revenue Market Share by Application in 2025
Figure 38. Mepolizumab Sales by Company in 2025 (Units)
Figure 39. Global Mepolizumab Sales Market Share by Company in 2025
Figure 40. Mepolizumab Revenue by Company in 2025 ($ millions)
Figure 41. Global Mepolizumab Revenue Market Share by Company in 2025
Figure 42. Global Mepolizumab Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Mepolizumab Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Mepolizumab Sales 2021-2026 (Units)
Figure 45. Americas Mepolizumab Revenue 2021-2026 ($ millions)
Figure 46. APAC Mepolizumab Sales 2021-2026 (Units)
Figure 47. APAC Mepolizumab Revenue 2021-2026 ($ millions)
Figure 48. Europe Mepolizumab Sales 2021-2026 (Units)
Figure 49. Europe Mepolizumab Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Mepolizumab Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Mepolizumab Revenue 2021-2026 ($ millions)
Figure 52. Americas Mepolizumab Sales Market Share by Country in 2025
Figure 53. Americas Mepolizumab Revenue Market Share by Country (2021-2026)
Figure 54. Americas Mepolizumab Sales Market Share by Type (2021-2026)
Figure 55. Americas Mepolizumab Sales Market Share by Application (2021-2026)
Figure 56. United States Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Mepolizumab Sales Market Share by Region in 2025
Figure 61. APAC Mepolizumab Revenue Market Share by Region (2021-2026)
Figure 62. APAC Mepolizumab Sales Market Share by Type (2021-2026)
Figure 63. APAC Mepolizumab Sales Market Share by Application (2021-2026)
Figure 64. China Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. India Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Mepolizumab Sales Market Share by Country in 2025
Figure 72. Europe Mepolizumab Revenue Market Share by Country (2021-2026)
Figure 73. Europe Mepolizumab Sales Market Share by Type (2021-2026)
Figure 74. Europe Mepolizumab Sales Market Share by Application (2021-2026)
Figure 75. Germany Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. France Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Mepolizumab Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Mepolizumab Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Mepolizumab Sales Market Share by Application (2021-2026)
Figure 83. Egypt Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Mepolizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Mepolizumab in 2026
Figure 89. Manufacturing Process Analysis of Mepolizumab
Figure 90. Industry Chain Structure of Mepolizumab
Figure 91. Channels of Distribution
Figure 92. Global Mepolizumab Sales Market Forecast by Region (2027-2032)
Figure 93. Global Mepolizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Mepolizumab Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Mepolizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Mepolizumab Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Mepolizumab Revenue Market Share Forecast by Application (2027-2032)
